These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6361908)

  • 1. Review: 6 keto-prostaglandin-E1.
    Moore PK; Griffiths RJ
    Prostaglandins; 1983 Oct; 26(4):509-17. PubMed ID: 6361908
    [No Abstract]   [Full Text] [Related]  

  • 2. Biological activities of 6-keto-prostaglandin E1.
    Lewis R; Schölkens BA; Beck G
    Prostaglandins Leukot Med; 1984 Dec; 16(3):303-24. PubMed ID: 6098901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-Keto-prostaglandin E1: its formation by platelets from prostacyclin and resistance to pulmonary degradation.
    Berry CN; Hoult JR
    Pharmacology; 1983; 26(6):324-30. PubMed ID: 6348806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of OP 1206, a prostaglandin E1 derivative, on guinea-pig platelet functions.
    Tsuboi T; Fujitani B; Maeda J; Yoshida K; Shimizu M; Kawasaki A; Okegawa T; Tsuboshima M
    Thromb Res; 1980 Dec 1-15; 20(5-6):573-80. PubMed ID: 7233385
    [No Abstract]   [Full Text] [Related]  

  • 5. Pharmacological evaluation of ONO 1206, a prostaglandin E1 derivative, as antianginal agent.
    Tsuboi T; Hatano N; Nakatsuji K; Fujitani B; Yoshida K; Shimizu M; Kawasaki A; Sakata M; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():347-9. PubMed ID: 7386273
    [No Abstract]   [Full Text] [Related]  

  • 6. 6-keto-prostaglandin E1 is not equipotent to prostacyclin (PGI2) as an antiaggregatory agent.
    Miller OV; Aiken JW; Shebuski RJ; Gorman RR
    Prostaglandins; 1980 Aug; 20(2):391-400. PubMed ID: 6251513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostaglandins: gastrointestinal effects and peptic ulcer disease.
    Wilson DE; Kaymakcalan H
    Med Clin North Am; 1981 Jul; 65(4):773-87. PubMed ID: 6268904
    [No Abstract]   [Full Text] [Related]  

  • 8. Catabolism of 6 keto PGE1: biological activation by the rat kidney in vitro.
    Moore PK; Griffiths RJ; Gaffen ZA
    Eur J Pharmacol; 1983 Jul; 91(2-3):311-5. PubMed ID: 6684573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of a 6-oxoprostaglandin E1-like substance from human platelets.
    Lofts FJ; Moore PK
    Clin Sci (Lond); 1983 Jan; 64(1):63-8. PubMed ID: 6681597
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of prostaglandins E1 and E2 on thrombocyte form and aggregation].
    Antonikov IM; Alekseev OV; Chernukh AM
    Biull Eksp Biol Med; 1982 Apr; 93(4):11-3. PubMed ID: 6952942
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 6-Keto-prostaglandin E1 inhibits the aggregation of human platelets.
    Wong PY; McGiff JC; Sun FF; Lee WH
    Eur J Pharmacol; 1979 Dec; 60(2-3):245-8. PubMed ID: 393526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasodilator actions of prostaglandin 6-keto-E1 in the pulmonary vascular bed.
    Hyman AL; Kadowitz PJ
    J Pharmacol Exp Ther; 1980 Jun; 213(3):468-72. PubMed ID: 7193724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Keto-prostaglandin E1-sensitive adenylate cyclase and binding sites in membranes from platelets and cultured smooth muscle cells.
    Oliva D; Bernini F; Corsini A; Nicosia S
    Biochem Pharmacol; 1984 Dec; 33(23):3755-8. PubMed ID: 6391491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antagonism of prostaglandins I2, E1 and D2 by prostaglandin E2 in human platelets.
    Bonne C; Martin B; Watada M; Regnault F
    Thromb Res; 1981 Jan 1-15; 21(1-2):13-22. PubMed ID: 6262942
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostaglandin-related renin release from rabbit renal cortical slices.
    Spokas EG; Wong PY; McGiff JC
    Hypertension; 1982; 4(3 Pt 2):96-100. PubMed ID: 7040243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interactions between dipyridamole and prostaglandin E1 with ADP-induced aggregation of rat platelet in whole blood.
    Touqui L; Hatmi M; Vargaftig BB
    Thromb Haemost; 1984 Jul; 51(3):410. PubMed ID: 6541815
    [No Abstract]   [Full Text] [Related]  

  • 17. Fibrinolytic activity of 6-keto-prostaglandin E1.
    Korbut R; Byrska-Danek A; Gryglewski RJ
    Thromb Haemost; 1983 Dec; 50(4):893. PubMed ID: 6686723
    [No Abstract]   [Full Text] [Related]  

  • 18. A comparison of the effects of prostacyclin and 6-keto-prostaglandin E1 on renin release in the isolated rat and rabbit kidney.
    Schwertschlag U; Stahl T; Hackenthal E
    Prostaglandins; 1982 Jan; 23(1):129-38. PubMed ID: 7038776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conversion of prostacyclin to 6 oxo prostaglandin E1 by rat, rabbit, guinea-pig and human platelets.
    Griffiths RJ; Moore PK
    Br J Pharmacol; 1983 Oct; 80(2):395-402. PubMed ID: 6360281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical and experimental study on platelet--preserving effect of prostaglandin E1 during extracorporeal circulation].
    Osada H; Kawada T; Hoson M; Funaki S; Arase K; Hiekata T; Noguchi T
    Nihon Kyobu Geka Gakkai Zasshi; 1982 Oct; 30(10):1656-63. PubMed ID: 6891710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.